Tg Therapeutics (TGTX) Return on Equity (2016 - 2025)
Historic Return on Equity for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 1.01%.
- Tg Therapeutics' Return on Equity rose 10900.0% to 1.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.01%, marking a year-over-year increase of 10900.0%. This contributed to the annual value of 0.12% for FY2024, which is 100.0% up from last year.
- Per Tg Therapeutics' latest filing, its Return on Equity stood at 1.01% for Q3 2025, which was up 10900.0% from 0.24% recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Return on Equity ranged from a high of 1.01% in Q3 2025 and a low of 6.01% during Q2 2023
- Over the past 5 years, Tg Therapeutics' median Return on Equity value was 0.66% (recorded in 2021), while the average stood at 1.11%.
- Per our database at Business Quant, Tg Therapeutics' Return on Equity surged by 95000bps in 2021 and then tumbled by -40600bps in 2023.
- Tg Therapeutics' Return on Equity (Quarter) stood at 1.28% in 2021, then tumbled by -125bps to 2.87% in 2022, then surged by 103bps to 0.08% in 2023, then soared by 45bps to 0.11% in 2024, then soared by 798bps to 1.01% in 2025.
- Its Return on Equity was 1.01% in Q3 2025, compared to 0.24% in Q2 2025 and 0.17% in Q1 2025.